Status:
COMPLETED
Caffeine Treatment in in the Delivery Room
Lead Sponsor:
University of Florence
Conditions:
Respiratory Distress Syndrome
Eligibility:
All Genders
1-10 years
Phase:
NA
Brief Summary
Background. In recent years, particular attention has been paid to all interventions that could help reduce the need for mechanical ventilation MV and, therefore, the risk of BPD. However, early appli...
Detailed Description
INTRODUCTION Background Mechanical ventilation (MV) is one of the most important risk factors for the development of bronchopulmonary dysplasia (BPD) in the preterm infant, due to the early pulmonary ...
Eligibility Criteria
Inclusion
- Inborn infants
- Infants with 25+0-29+6 weeks of gestational age
- Infants who do not require MV in the delivery room
Exclusion
- Maternal consumption of caffeine before giving birth (\> 2 cups of coffee in the 6 hours before birth)
- Major congenital malformations
- Chromosomal syndromes
- Fetal hydrops
- Inherited metabolic disorders
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04044976
Start Date
August 1 2019
End Date
August 31 2021
Last Update
March 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Neonatology, Careggi University Hospital
Florence, Italy, 50134